Sarina Tanimoto is CHIEF MEDICAL OFFICER of Silverback Therapeutics, Inc.. Currently has a direct ownership of 3.43 Million shares of SBTX, which is worth approximately $0. The most recent transaction as insider was on Dec 06, 2024, when has been sold 25,665 shares (Common Stock) at a price of $4.93 per share, resulting in proceeds of $126,528. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.43M
0.75% 3M change
4.78% 12M change
Total Value Held $0

Sarina Tanimoto Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 06 2024
BUY
Exercise of conversion of derivative security
$126,528 $4.93 p/Share
25,665 Added 0.74%
3,433,512 Common Stock
Apr 23 2024
BUY
Exercise of conversion of derivative security
$149,332 $1.14 p/Share
130,993 Added 3.7%
3,407,847 Common Stock
May 17 2023
SELL
Bona fide gift
-
1,050,000 Reduced 24.27%
3,276,854 Common Stock
Nov 08 2022
BUY
Grant, award, or other acquisition
-
4,326,854 Added 50.0%
4,326,854 Common Stock
ST

Sarina Tanimoto

CHIEF MEDICAL OFFICER
San Diego, CA

Track Institutional and Insider Activities on SBTX

Follow Silverback Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBTX shares.

Notify only if

Insider Trading

Get notified when an Silverback Therapeutics, Inc. insider buys or sells SBTX shares.

Notify only if

News

Receive news related to Silverback Therapeutics, Inc.

Track Activities on SBTX